This suggests a new role for ARHGAP21 in energetic metabolism and prompts us to consider GAP protein members as possible targets for the prevention and treatment of obesity and related diseases. The gene discussed is ARHGAP21; the disease is obesity due to melanocortin 4 receptor deficiency.